MANAGEMENT
BOARDS OF DIRECTORS
The Board of Directors at AFYX Therapeutics A/S is composed of a distinguished and diverse group of leaders, each bringing deep expertise from across the pharmaceutical industry and adjacent sectors.
Our directors contribute strategic insight shaped by extensive experience in:
- Medical Research & Clinical Development
- Global Market Strategy & Commercialization
- Branding & Corporate Identity
- Regulatory Affairs & Clinical Development
- Corporate Finance & General Management
This breadth of qualifications ensures a comprehensive and forward-looking approach to governance, decision-making, and long-term value creation.
Reflecting the global community we serve, our board brings together a wide range of professional disciplines and cultural perspectives. This diversity fosters innovative thinking and enables us to address complex challenges with creativity, integrity, and accountability.
BOARD OF DIRECTORS
Dr. Ole Baadsgaard
Chairman
Dr. Baadsgaard has previously been Chief Medical Officer in both Genmab A/S and Y-mAbs Therapeutics, Inc. He has been lead author or contributor to more than 100 peer-reviewed journal publications and author on more than 20 patents and pending patent applications.
Dr. Claus J. Møller-San Pedro
Board Member & CEO
Dr. Møller is the Founder and CEO of our company. Previously Dr. Møller was Co-Founder and CEO of Y-mAbs, Inc and secured its IPO in 2018 as well as getting Danyelza FDA approved in 2020.
Pia Møller-San Pedro
Board Member
Ms. Møller-San Pedro brings +20 years of international experience as a strategic Manager and part of Executive Management. Ms. Møller-San Pedro brings significant commercial and branding expertise to our board.
Mr. Søren Kjær
Board Member
Mr. Kjær brings +30 years of international banking experience. His background includes Venture Capital Investments and Board Positions in Life Science and Venture Capital companies.
MANAGEMENT
Dr. Claus J. Møller-San Pedro
Board Member &
Chief Executive Officer
Pernille Træholt
VP Chief Development Officer
Pia Møller-San Pedro
Board Member &
SVP, Chief Operating Officer
Fredrik D. Knudsen
Senior Financial Director
Michael N. Rimikis
VP Business Development & Medical Network
SEND US A MESSAGE
AFYX THERAPEUTICS HQ
Slotsmarken 11, 1.tv.
DK-2970 Hørsholm
Denmark
VAT: 38793594
Phone: +45 7174 7174
info@afyxtx.com
AFYX NORWAY
Gaustadalléen 21
NO-0349 Oslo
Norway
VAT: 922 558 221
Phone: +47 2396 7174